Cargando…

Elevated expression of lung development-related protein HSP90β indicates poor prognosis in non-small cell lung cancer through affecting the cell cycle and apoptosis

Detalles Bibliográficos
Autores principales:	Wang, Xiang, Wang, Yaru, Feng, Lin, Wang, Minghui, Zhang, Kaitai, Mao, Yousheng, Xiao, Ting, Cheng, Shujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907212/ https://www.ncbi.nlm.nih.gov/pubmed/33633110 http://dx.doi.org/10.1038/s41392-021-00465-y

Ejemplares similares

Proliferation genes in lung development associated with the prognosis of lung adenocarcinoma but not squamous cell carcinoma
por: Li, Ping, et al.
Publicado: (2017)

Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma
por: Wu, Quanyou, et al.
Publicado: (2022)

High Expression of Plasma Extracellular HSP90α is Associated With the Poor Efficacy of Chemotherapy and Prognosis in Small Cell Lung Cancer
por: Huang, Baoyue, et al.
Publicado: (2022)

The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells
por: Gomez-Casal, Roberto, et al.
Publicado: (2015)

Multi-omics analysis unravels the underlying mechanisms of poor prognosis and differential therapeutic responses of solid predominant lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2023)

Elevated FOXA1 Expression Indicates Poor Prognosis in Liver Cancer due to Its Effects on Cell Proliferation and Metastasis
por: Liu, Zhenrong, et al.
Publicado: (2022)

High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer
por: Zhang, Shuming, et al.
Publicado: (2019)

HSP-90 Inhibitor Ganetespib is Synergistic with Doxorubicin in Small Cell Lung Cancer
por: Lai, Chien-Hao, et al.
Publicado: (2013)

Gene Expression Profiling in Human Lung Development: An Abundant Resource for Lung Adenocarcinoma Prognosis
por: Feng, Lin, et al.
Publicado: (2014)

Cell cycle‐related and expression‐elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non‐small‐cell lung cancer
por: Li, Weimiao, et al.
Publicado: (2018)

Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients
por: Biaoxue, Rong, et al.
Publicado: (2012)

Diagnostic value of HSP90α and related markers in lung cancer
por: Yuan, Zhimin, et al.
Publicado: (2022)

Induction of Premature Senescence by Hsp90 Inhibition in Small Cell Lung Cancer
por: Restall, Ian J., et al.
Publicado: (2010)

The diagnostic value of Hsp90α in monitoring treatment responses in lung cancer
por: WANG, Min, et al.
Publicado: (2022)

UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma
por: Tu, Zhenbo, et al.
Publicado: (2020)

HSP90 as a novel molecular target in non-small-cell lung cancer
por: Esfahani, Khashayar, et al.
Publicado: (2016)

Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients
por: Tang, Yaoxiang, et al.
Publicado: (2021)

Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma
por: Li, Ping, et al.
Publicado: (2016)

Circulating tumour cells in patients with lung cancer universally indicate poor prognosis
por: Jin, Fukang, et al.
Publicado: (2022)

The Molecular Chaperone Hsp90 Is Required for Cell Cycle Exit in Drosophila melanogaster
por: Bandura, Jennifer L., et al.
Publicado: (2013)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle
por: Tang, Xiaolong, et al.
Publicado: (2023)

Prognostic value of molecular events from negative surgical margin of non-small-cell lung cancer
por: Cao, Bangrong, et al.
Publicado: (2016)

Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer
por: Biaoxue, Rong, et al.
Publicado: (2018)

Prognostic value of the mRNA expression of members of the HSP90 family in non-small cell lung cancer
por: Liu, Kang, et al.
Publicado: (2019)

Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition
por: Gomez-Casal, Roberto, et al.
Publicado: (2015)

HSP90 Inhibition Suppresses Lipopolysaccharide-Induced Lung Inflammation In Vivo
por: Lilja, Andrew, et al.
Publicado: (2015)

Identification of Predictive Biomarkers of Response to HSP90 Inhibitors in Lung Adenocarcinoma
por: Marrugal, Ángela, et al.
Publicado: (2021)

Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma
por: Fan, Weibing, et al.
Publicado: (2017)

The Indication of Poor Prognosis by High Expression of ENO1 in Squamous Cell Carcinoma of the Lung
por: Huang, Wan-Ying, et al.
Publicado: (2021)

Hsp90 S-nitrosylation at Cys521, as a conformational switch, modulates cycling of Hsp90-AHA1-CDC37 chaperone machine to aggravate atherosclerosis
por: Zhao, Shuang, et al.
Publicado: (2022)

Elevated M-MDSCs in Circulation Are Indicative of Poor Prognosis in Diffuse Large B-Cell Lymphoma Patients
por: Wang, Zhitao, et al.
Publicado: (2021)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer
por: Wang, Jiying, et al.
Publicado: (2021)

Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
por: Proia, David A., et al.
Publicado: (2012)

Quantitative proteomics reveals molecular mechanism of gamabufotalin and its potential inhibition on Hsp90 in lung cancer
por: Zhang, Liyuan, et al.
Publicado: (2016)

Elevated fibrous sheath interacting protein 1 levels are associated with poor prognosis in non-small cell lung cancer patients
por: Mao, Yuqiang, et al.
Publicado: (2017)

Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma
por: Masuda, Ryota, et al.
Publicado: (2017)

Elevated expression of HSP90 and the antitumor effect of an HSP90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma
por: Bekki, Hirofumi, et al.
Publicado: (2015)

High expression of DARS2 indicates poor prognosis in lung adenocarcinoma
por: Jiang, Yingfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vk69jupefvdvcfh233rcreuk51